Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page
- Check4 days agoChange DetectedNo additions or deletions are present in the update data for this page. This indicates the page content remains unchanged within the provided scope.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, indicating a minor site release/version change without any change to the study content.SummaryDifference0.2%

- Check18 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check26 days agoChange DetectedLocation entry updated from Padua, Italy, 35128 to Padova, Italy, 35128 to reflect the Italian city name.SummaryDifference0.1%

- Check33 days agoChange DetectedLayout and styling changes are visible in the screenshots, while core study content remains the same.SummaryDifference0.1%

- Check40 days agoChange DetectedNo additions or deletions are visible. The page content and layout appear unchanged.SummaryDifference0.1%

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.